1. Home
  2. ORMP vs MCHX Comparison

ORMP vs MCHX Comparison

Compare ORMP & MCHX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Oramed Pharmaceuticals Inc.

ORMP

Oramed Pharmaceuticals Inc.

N/A

Current Price

$4.62

Market Cap

170.3M

Sector

Health Care

ML Signal

N/A

Logo Marchex Inc. Class B

MCHX

Marchex Inc. Class B

HOLD

Current Price

$1.23

Market Cap

67.3M

ML Signal

HOLD

Company Overview

Basic Information
Metric
ORMP
MCHX
Founded
2002
2003
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Business Services
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
170.3M
67.3M
IPO Year
2010
2003

Fundamental Metrics

Financial Performance
Metric
ORMP
MCHX
Price
$4.62
$1.23
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
220.5K
19.5K
Earning Date
05-14-2026
05-14-2026
Dividend Yield
6.51%
N/A
EPS Growth
412.50
N/A
EPS
2.76
N/A
Revenue
$2,000,000.00
$90,291,000.00
Revenue This Year
N/A
$5.37
Revenue Next Year
N/A
N/A
P/E Ratio
$1.69
N/A
Revenue Growth
49.25
N/A
52 Week Low
$2.09
$1.32
52 Week High
$5.47
$2.04

Technical Indicators

Market Signals
Indicator
ORMP
MCHX
Relative Strength Index (RSI) 44.66 18.09
Support Level $3.91 N/A
Resistance Level $5.10 $1.73
Average True Range (ATR) 0.22 0.12
MACD -0.07 -0.06
Stochastic Oscillator 3.14 0.00

Price Performance

Historical Comparison
ORMP
MCHX

About ORMP Oramed Pharmaceuticals Inc.

Oramed Pharmaceuticals Inc is a pharmaceutical company that is engaged in the research and development of pharmaceutical solutions with a technology platform that allows for the oral delivery of therapeutic proteins. The company has developed an oral dosage form intended to withstand the harsh environment of the gastrointestinal tract and effectively deliver active insulin or other proteins. Its product pipeline includes ORMD-0801 for Diabetes, ORMD-0801 for NASH, and ORMD 0901.

About MCHX Marchex Inc. Class B

Marchex Inc provides AI-based conversational intelligence and analytics solutions that generate insights from customer communications data. The company's products support sales, marketing, and executive teams in analyzing customer interactions across communication channels and informing business decisions. It serves companies operating in business-to-business-to-consumer (B2B2C) markets across multiple industries like automotive, home services, healthcare, real estate, and advertising. The company operates in a single segment: conversational analytics and related solutions. The company generates the majority of revenue from its conversational intelligence product offerings. Geographically, it generates the maximum revenue from the United States.

Share on Social Networks: